WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,798 Cr | ₹2,651 Cr | ₹3,230 Cr | ₹2,708 Cr | ₹2,844 Cr |
What is the latest Revenue of WOCKHARDT ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,798 Cr |
| Mar2024 | ₹2,651 Cr |
| Mar2023 | ₹3,230 Cr |
| Mar2022 | ₹2,708 Cr |
| Mar2021 | ₹2,844 Cr |
How is Revenue of WOCKHARDT Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,798 Cr | 5.55 | |
| Mar2024 | ₹2,651 Cr | -17.93 | |
| Mar2023 | ₹3,230 Cr | 19.28 | |
| Mar2022 | ₹2,708 Cr | -4.78 | |
| Mar2021 | ₹2,844 Cr | - | |
Compare Revenue of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹22,294.2 Cr | 0.5% | -5.4% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹381,326.0 Cr | -0.2% | -6.3% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,299.0 Cr | 3.3% | -3.4% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,821.0 Cr | -0.7% | 3.8% | 26.3% | Stock Analytics | |
| CIPLA | ₹106,655.0 Cr | -3% | -11.8% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,861.0 Cr | 6% | -3.5% | -4.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | 0.5% |
-5.4% |
3.9% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses